Kestra Medical Technologies Launches Cardiac Recovery System
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a leader in wearable medical devices, is excited to announce its groundbreaking participation in the Heart Failure Society of America (HFSA) Annual Scientific Meeting. This major event, held from September 26 to 29, showcases the company's commitment to redefining the landscape of cardiac care.
Innovative Presentation at HFSA
During the HFSA conference, held in a dynamic setting, Kestra will present its state-of-the-art Cardiac Recovery System (CRS) at booth #920. This advanced platform is anchored by the ASSURE Wearable Cardioverter Defibrillator, a device designed to proactively guard against sudden cardiac death, filling a critical void in the early phase of heart failure recovery.
Hands-On Demonstrations at the Conference
Attendees will have the opportunity to engage with the CRS platform through immersive experiences and practical demonstrations. These interactions will showcase how the system not only enhances patient safety but also strengthens the vital connection between clinicians and their patients, facilitating a collaborative approach to care.
Leadership Insights on Cardiac Care
Kestra's leadership is enthusiastic about this opportunity to highlight their new solutions. "Our presence at HFSA amplifies Kestra's dedication to improving care for heart failure patients," stated Brian Webster, President and Chief Executive Officer of Kestra Medical Technologies. He emphasized, "The Cardiac Recovery System is set to revolutionize management strategies for sudden cardiac arrest risks, equipping healthcare professionals with the tools they need to safeguard their patients. This initiative reinforces our commitment to fostering safe recovery environments for those at risk."
Participation in Comprehensive Discussions
In addition to the informative exhibit, Kestra will be involved in the Devices in Heart Failure Meeting on September 26. This gathering will provide a platform for attendees to examine the ASSURE system and understand its integration within clinical workflows, which is crucial in supporting guideline-directed medical therapy.
About Kestra Medical Technologies
Kestra Medical Technologies is a pioneering company focused on wearable medical devices that are transforming cardiovascular care through innovative monitoring and intervention technologies. Their goal is to enhance patient outcomes, making healthcare more intuitive and connected. For more details about their initiatives and products, visit www.kestramedical.com.
Media and Investor Contacts
For media inquiries, please contact Rhiannon Pickus at Rhiannon.Pickus@kestramedical.com. Investors seeking further information can reach out to Neil Bhalodkar at Neil.Bhalodkar@kestramedical.com.
Frequently Asked Questions
What is the Cardiac Recovery System by Kestra Medical?
The Cardiac Recovery System (CRS) is an innovative platform designed to enhance the management of patients at risk of sudden cardiac arrest, particularly during the recovery phase of heart failure.
How does the ASSURE system work?
The ASSURE Wearable Cardioverter Defibrillator is a key feature of the CRS, providing protective monitoring and actionable insights for both patients and healthcare providers.
What can attendees expect at the HFSA conference?
Attendees can expect immersive experiences, hands-on demonstrations of the CRS, and discussions on how it integrates into clinical practices.
Who leads Kestra Medical Technologies?
The company is led by Brian Webster, who emphasizes the commitment to advancing heart failure care through innovative solutions.
Where can I find more information about Kestra Medical Technologies?
More information is available on their official website, www.kestramedical.com, which highlights their products and commitment to improving patient health outcomes.
